Abstract
Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors presented with TMEP. TMEP is often refractory to therapy; however, our patient responded to treatment with PUVA.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 922-924 |
| Number of pages | 3 |
| Journal | International journal of dermatology |
| Volume | 43 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 1 2004 |
ASJC Scopus subject areas
- Dermatology
Fingerprint Dive into the research topics of 'Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder'. Together they form a unique fingerprint.
Cite this
Martin, L. K., Romanelli, P., Ahn, Y. S., & Kirsner, R. S. (2004). Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder. International journal of dermatology, 43(12), 922-924. https://doi.org/10.1111/j.1365-4632.2004.02249.x